S&P 500 and NASDAQ hit record highs, metals rally, futures down 7 points

Published 19-AUG-2020 09:48 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

The S&P/ASX 200 index (XJO) gained 47 points or 0.8% on Tuesday, closing at 6123 points.

The key catalysts behind the move were generally positive earnings results and news that a stimulus package may be imminent in the US, a development that should propel their markets.

However, as we write, the necessary legislation hasn’t been passed and the cheque is nowhere near in the mail.

Consequently, it could be argued that it is a little early to factor in potential upside from stimulus measures in US.

On the negative side of the ledger there was one very tangible development asChina launched an anti-dumping investigation into Australian wine exports, arguably the thin edge of the wedge for the continued imposition of tariffs on our agricultural sector following recent targeting of our barley and beef industries.

This had a substantial impact on Treasury Wine Estate (ASX: TWE) yesterday as its shares plunged 15%.

Despite strength in US markets, the ASX SPI200 is down seven points to 6062 points.

24 hours

There was little movement in other Asia-Pacific markets yesterday with the Hang Seng and the Shanghai Composite only gaining 20 points and 12 points respectively, while the Nikkei 225 shed 45 points or 0.2% to close at 23,051 points.

The mood was decidedly negative in Europe with the FTSE 100 setting the tone as it came off 50 points or 0.8% to close at 6076 points.

In mainland Europe, the CAC 40 was hardest hit as it fell 34 points or 0.7%, closing at 4938 points.

The DAX drops 39 points or 0.3% to close at 12,881 points.

The NASDAQ continued to be the standout performer in the US, notching up a new record of 11,230 points before closing at 11,210 points, up 0.7%.

The rally in technology stocks also helped to propel the S&P 500 to a new all-time closing high of 3389 points after hitting 3395 points in morning trading.

However, the Dow came off 67 points or 0.2% to close at 27,778 points.

On the commodities front, gold pushed up about 1% to US$2020 per ounce before closing at US$2013 per ounce.

The Brent Crude Oil Continuous Contract had a bumpy day before retracing late in the session to close at US$45 per barrel.

Iron ore was the big news story as it soared more than 5% to US$128.50 per tonne, suggesting it should be a good day for Rio, BHP and FMG.

There was also strength in base metals with copper hitting US$2.97 per pound, a level it hasn’t traded at since mid-2018.

Lead recorded its fourth consecutive day of gains, finishing only 0.3% shy of US$0.90 per pound, a level it hasn’t traded at since the start of year.

Nickel continued its rally, hitting US$6.60 per pound, a level it hasn’t traded at since October last year.

While zinc made a nominal gain to finish at US$1.11 per pound, this was still a significant achievement as it is only 2% shy of a seven month high.

With this across-the-board strength in base metals, South32 Ltd (ASX:S32) may be a stock to watch today.

The Australian dollar continued to strengthen against the US dollar, and it is now fetching close to US$0.725.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X